Virtual Tour
Media
NEWS
Contact Us
Patients
NEUROLOGY
CinnoVex
ReciGen
CinnoMer
CinnoTec
ONCOLOGY & HAEMATOLOGY
PegaGen
CinnaPoietin
KidiPeg
GYNECOLOGY & HORMONE
Cinnal-f
CinnaFact
CinnaTropin
Melitide
RHEUMATOLOGY
CinnoPar
CinnoRA
Healthcare Professionals
NEUROLOGY
CinnoVex
ReciGen
CinnoMer
CinnoTec
ONCOLOGY & HAEMATOLOGY
PegaGen
CinnaPoietin
KidiPeg
GYNECOLOGY & HORMONE
Cinnal-f
CinnaTropin
CinnaFact
Melitide
RHEUMATOLOGY
CinnoPar
CinnoRA
Capabilities
Our Technology
Business Development
Our Manufacturing Sites
Research and Development
About Us
Presidential Note
About CinnaGen
Mission Statement
Policy
Management Team
Search
Virtual Tour
Media
NEWS
Contact Us
Happy New Year
Jan2020 / PR /
Previuos News
CinnaGen ilac has been established in 2019
Next News
Researchers announced safety and effectiveness of ReciGen (interferon beta-1a 44 mcg manufactured by CinnaGen Co.) on COVID-19 patients
tags:
New year
More in this category:
Home
Happy New Year
Back top Top
